Author:
Peng Zhiyong,Sun Tongwen,Zhang Xijing,Zhang Haibo
Abstract
AbstractAnalgesia and sedation are important treatment strategies in the intensive care unit (ICU). Due to the opioid crisis, opioid-sparing medications become the focus of clinical studies. Ketamine and its isomers (mainly esketamine) are intravenous anesthetics that possess sedative, analgesic, and anesthetic effects, which have recently attracted the attention of critical care physicians. However, the application of ketamine/esketamine in ICU is limited and inexperienced. Experts from the Critical Care Medicine Professional Committee of the Chinese Research Hospital Association drafted this consensus based on the current clinical evidence to provide recommendations for the application of ketamine/esketamine in different fields of critical care, including sepsis and septic shock, endotracheal intubation, neurocritical care, respiratory critical care, post cardiac surgery care, burn and depression in ICU. Meanwhile, this expert consensus also appeals for more high-quality clinical trials to facilitate more reasonable guidelines in this area.
Funder
Major Project of Henan Provincial-Ministerial Co-construction on Medical Science and Technology
Publisher
Springer Science and Business Media LLC
Reference57 articles.
1. Xu JY, Wu ZS, Chang W, et al. Comparison of the effects of intravenous sedatives on outcome in adult critically ill patients: a bayesian network analysis. Intens Care Res. 2022;2:12–22.
2. Society Of Critical Care Medicine Chinese Medical Association. Guidelines for analgesia and sedation treatment in intensive care unit of Chinese adults. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2018;30(6):497–514 (Chinese).
3. Laskowski K, Stirling A, McKay WP, et al. A systematic review of intravenous ketamine for postoperative analgesia. Can J Anesth/J Can Anesth. 2011;58(10):911–23.
4. Weber F, Wulf H, Gruber M, et al. S-ketamine and S-norketamine plasma concentrations after nasal and i.v. administration in anesthetized children. Paediatr Anaesth. 2004;14(12):983–8.
5. Fanta S, Kinnunen M, Backman JT, et al. Population pharmacokinetics of S-ketamine and norketamine in healthy volunters after intravenous and oral dosing. Eur J Clin Pharmacol. 2015;71(4):441–7.